Market revenue in 2023 | USD 9,074.6 million |
Market revenue in 2030 | USD 10,525.6 million |
Growth rate | 2.1% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Human & Tumor Genetics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 53.97% in 2023. Horizon Databook has segmented the UK clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Most tests are conducted in the UK in NHS laboratories. However, there are many private labs in the country, which can make it difficult for new private players to enter the UK market, owing to the low cost of tests provided by the NHS.
The high number of tests conducted every year in the UK, and a large number of NHS labs in the country are expected to boost the market in the UK. The In Vitro Diagnostics Regulation (IVDR) requires device manufacturers to perform clinical performance studies and provide evidence of performance and safety proportionate, along with a device’s allocated risk class.
The manufacturers have to retain and collect post market performance data as a part of the ongoing evaluation of possible safety risks.
Horizon Databook provides a detailed overview of country-level data and insights on the UK clinical laboratory service market , including forecasts for subscribers. This country databook contains high-level insights into UK clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account